neurodegenerative-diseases-1920x640
Whitepaper

Targeted protein degradation: a novel therapeutic strategy for neurodegenerative diseases

Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading disease-linked proteins. Despite challenges in delivery and stability, advancements in TPD technologies show potential in addressing diseases like Alzheimer’s, Parkinson’s, and Huntington’s.

Get this White Paper and have details about:

  • Targets Undruggable Proteins
  • Complete Protein Elimination
  • Innovative Technologies
  • And more…

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Targeted protein degradation: a novel therapeutic strategy for neurodegenerative diseases

Download Whitepaper